Literature DB >> 167649

Endocrine therapy of breast cancer.

W L McGuire.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 167649     DOI: 10.1146/annurev.me.26.020175.002033

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  14 in total

1.  ER beta inhibits proliferation and invasion of breast cancer cells.

Authors:  G Lazennec; D Bresson; A Lucas; C Chauveau; F Vignon
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

Review 2.  Steroid hormone receptors in the regulation of differentiation. A review.

Authors:  K S McCarty; K S McCarty
Journal:  Am J Pathol       Date:  1977-03       Impact factor: 4.307

3.  Estrogen receptor protein assays in human breast cancer.

Authors:  R M Nakamura
Journal:  West J Med       Date:  1975-12

Review 4.  Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  M M Buckley; K L Goa
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 5.  Suppression of estrogens with aminoglutethimide and hydrocortisone (medical adrenalectomy) as treatment of advanced breast carcinoma: a review.

Authors:  R J Santen
Journal:  Breast Cancer Res Treat       Date:  1981       Impact factor: 4.872

6.  The significance of cancer cells contaminating postoperative seroma.

Authors:  N Vujicić; M Dominis; J Rogan-Grgas; P Nola
Journal:  Clin Exp Metastasis       Date:  1986 Jul-Sep       Impact factor: 5.150

7.  Autoradiographic localization of 3H-ORG 2058, a synthetic progestin, in the mammary glands of the baboon.

Authors:  F J Weaker; P J Sheridan
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

Review 8.  ERbeta in breast cancer--onlooker, passive player, or active protector?

Authors:  Emily M Fox; Rebecca J Davis; Margaret A Shupnik
Journal:  Steroids       Date:  2008-04-20       Impact factor: 2.668

9.  Value of 8S/4S fractionation of estrogen receptors (ER) for prediction of response to hormonal manipulation in metastatic breast cancer.

Authors:  G Wang; C L Vogel; S G Hilsenbeck; W Voigt; S Thomsen
Journal:  Breast Cancer Res Treat       Date:  1984       Impact factor: 4.872

10.  Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

Authors:  Emily M Fox; Teresa M Bernaciak; Jie Wen; Amanda M Weaver; Margaret A Shupnik; Corinne M Silva
Journal:  Mol Endocrinol       Date:  2008-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.